Short Interest in Terumo Co. (OTCMKTS:TRUMY) Increases By 46.2%

Terumo Co. (OTCMKTS:TRUMY) was the recipient of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 3,800 shares, a growth of 46.2% from the March 31st total of 2,600 shares. Based on an average daily volume of 137,800 shares, the short-interest ratio is currently 0.0 days.

Terumo Stock Performance

Shares of OTCMKTS TRUMY opened at $16.60 on Friday. The company has a current ratio of 1.90, a quick ratio of 1.13 and a debt-to-equity ratio of 0.06. Terumo has a 12-month low of $12.56 and a 12-month high of $20.60. The firm has a market capitalization of $24.75 billion, a price-to-earnings ratio of 34.95 and a beta of 0.65. The firm has a 50 day moving average of $21.13 and a 200 day moving average of $17.67.

Terumo (OTCMKTS:TRUMY) last issued its quarterly earnings data on Wednesday, February 7th. The company reported $0.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.14. Terumo had a net margin of 11.14% and a return on equity of 8.26%. The firm had revenue of $1.62 billion during the quarter. On average, research analysts anticipate that Terumo will post 0.57 earnings per share for the current year.

Terumo Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.